Genotyping Market Size and Forecast (2021 – 2031)

PCR Segment, by Technology to Account Largest Share in Genotyping Market during 2023–2031

According to our new research study on “Genotyping Market Forecast to 2031 – Global Analysis – by Product Type, Technology, Application, End User, and Geography,” the market was valued at US$ 30.44 billion in 2023 and is projected to reach US$ 154.35 billion by 2031; it is expected to register a CAGR of 22.5% during 2023–2031. Use in the diagnosis of genetic and rare diseases, and technological advancements and rising R&D investments in the biotechnology and pharmaceutical industries are among the factors contributing to genotyping market growth. However, the high cost of equipment and shortage of skilled professionals hamper the market growth. Further, the increasing popularity of personalized medicine is expected to bring new genotyping market trends in the coming years.

According to the National Health Service of England, personalized medicine is the medical treatment tailored to the unique traits of each patient. The method is based on scientific advancements that provide an understanding of a person’s unique genetic and molecular profile that contributes to their susceptibility to diseases as well as helps determine the safest and most effective medical treatments. Genomic medicine, guided by each person’s unique genetic, clinical, and environmental information, is a fundamental component of personalized medicine. The fundamentals of personalized medicine involve the standardization, development, and integration of various essential tools into health systems and clinical workflows for the whole-genome studies of transcription, sequence variation, proteins, and metabolites. Health risk assessment, family health history, and clinical decision assistance for complex risk and predictive information are combined with genomic data to detect individual risks and guide clinical treatment, laying the groundwork for a more informed and effective patient care approach.

DNA-based risk assessment for common complex diseases, genome-guided therapy, dose selection, and molecular signatures for cancer diagnosis and prognosis are examples of genome information has already enabled personalized health care. The integration of personalized medicine with healthcare can aid in more precise diagnoses, enable the prediction of disease risk before the occurrence of symptoms and provide individualized treatment plans with maximum safety and efficiency. Genotype data can be utilized as a guideline to determine the correct warfarin dose. The Clinical Pharmacogenetics Implementation Consortium has developed genotype-based drug guidelines to assist physicians in optimizing pharmacological therapies based on genetic test results. Genomic analysis of tumors can help tailor therapeutic approaches for treating individuals with hereditary cancer.

Although scientific discoveries related to personalized medicine are making their way from labs to clinics, the widespread acceptance of personalized medicine necessitates significant changes in regulatory, reimbursement procedures, and legislative privacy laws for rapid adoption of these medicines. Thus, increasing awareness and popularity of personalized medicine due to ongoing researches and use of genome editing techniques is expected to act as a trend for growth of the genotyping market.

Based on product type, the genotyping market is segmented into instruments, reagents and kits, bioinformatics, and genotyping services. The reagents and kits segment held the largest market share in 2023.

Based on technology, the genotyping market is divided into microarrays, capillary electrophoresis, sequencing, matrix-assisted laser desorption/ionization-time of flight (Maldi-ToF) mass spectrometry, polymerase chain reaction (PCR), and others. The PCR segment held the largest market share in 2023. Polymerase chain reaction (PCR) is widely used to make millions of copies of a specific DNA sample. The sample magnification ability of this technique allows scientists to work with minute samples of DNA. The magnified DNA may be envisioned by gel electrophoresis or processed with restriction enzymes and cloned into a plasmid. PCR has practical applications in genetic testing, forensics, and diagnostics. The technique can be utilized to amplify genes or markers associated with genetic disorders in prenatal testing. PCR can also be used to test for the presence of certain bacteria or DNA viruses in a patient’s body—if the pathogen is present, it may be possible to amplify regions of its DNA from a blood or tissue sample. Most PCR methods magnify DNA fragments of lengths ranging from 0.1 and 10 kilobase pairs (kbp), while some techniques allow for amplifying fragments up to 40 kbp. The amount of amplified product is determined on the basis of the substrates leftover in the reaction.

Various pharmaceutical and biopharmaceutical companies offer PCR systems, reagents, and kits for pharmacogenomic and drug development applications. For instance, Thermo Fisher Scientific, Inc. offers a real-time PCR services for pharmacogenomic applications, which works by combining the power of QuantStudio 12K Flex Real-time PCR System with qualified TaqMan genotyping assays. These assays deliver the sample-to-answer workflow that easily allows pharmacogenomic testing, which is marked as their unique feature. Other prominent features of this real-time PCR solution include its fully qualified content, flexible formats, extensive target menu, and cost-effective operations.

In June 2022, Bio-Rad Laboratories launched the CFX Duet Real-Time PCR System. This singleplex and duplex quantitative polymerase chain reaction (qPCR) assay development platform features factory calibration for popular dyes that allows precise measurement of up to two targets in genotyping and multiple gene expression analysis without using passive reference dies. The device has in-built thermal gradient functionality, allowing for optimization in fewer runs.

By application, the market is segmented into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. The diagnostics and personalized medicine segment held the largest share of the market in 2023.

Based on end user, the genotyping market is divided into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others. The pharmaceutical and biopharmaceutical segment held the largest genotyping market share in 2023.

F. Hoffmann-La Roche Ltd., Integrated DNA Technologies, Inc. (Danaher), Qiagen, Merck KGaA, Eurofins Genomics, Thermo Fisher Scientific Inc., BioTek Instruments, Inc., Xcelris Genomics, Trimgen Corporation, and Illumina, Inc. are among the leading companies operating in the global genotyping market.

Companies operating in the genotyping market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the genotyping market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall genotyping market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the genotyping market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the global genotyping market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth global market trends and outlook coupled with the factors driving the genotyping market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Genotyping Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Global Market Share Analysis
4.3.1 Global Market Share (%) of Leading Players for NGS Library Preparation
4.3.2 Global Market Share (%) of Leading Player for Genotyping
4.3.3 Global Market Share (%) of Leading Player for Gene Expression
5. Genotyping Market – Key Market Dynamics
5.1 Genotyping Market – Key Market Dynamics
5.2 Market Drivers:
5.2.1 Use in Diagnosis of Genetic and Rare Diseases
5.2.2 Technological Advancements and Rising R&D Investments in Biotechnology and Pharmaceutical Industry
5.3 Market Restraints
5.3.1 High Cost of Equipment and Shortage of Skilled Professionals
5.4 Market Opportunities
5.4.1 Expanding Range of Applications
5.5 Future Trends
5.5.1 Increasing Popularity of Personalized Medicine
5.6 Impact of Drivers and Restraints:
6. Genotyping Market – Global Market Analysis
6.1 Genotyping Market Revenue (US$ Million), 2021–2031
7. Genotyping Market Analysis – by Product Type
7.1 Instruments
7.1.1 Overview
7.1.2 Instruments: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Reagents and Kits
7.2.1 Overview
7.2.2 Reagents and Kits: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Bioinformatics
7.3.1 Overview
7.3.2 Bioinformatics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Genotyping Services
7.4.1 Overview
7.4.2 Genotyping Services: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8. Genotyping Market Analysis – by Technology
8.1 Microarray
8.1.1 Overview
8.1.2 Microarray: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Capillary Electrophoresis
8.2.1 Overview
8.2.2 Capillary Electrophoresis: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Sequencing
8.3.1 Overview
8.3.2 Sequencing: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Polymerase Chain Reaction (PCR)
8.4.1 Overview
8.4.2 Polymerase Chain Reaction (PCR): Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Matrix-Assisted Laser Desorption / MALDI-TOF
8.5.1 Overview
8.5.2 Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Other Technologies
8.6.1 Overview
8.6.2 Other Technologies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9. Genotyping Market Analysis – by Application
9.1 Pharmacogenomics
9.1.1 Overview
9.1.2 Pharmacogenomics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Diagnostics and Personalized Medicine
9.2.1 Overview
9.2.2 Diagnostics and Personalized Medicine: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Animal Genetics
9.3.1 Overview
9.3.2 Animal Genetics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Agricultural Biotechnology
9.4.1 Overview
9.4.2 Agricultural Biotechnology: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.5 Other Applications
9.5.1 Overview
9.5.2 Other Applications: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10. Genotyping Market Analysis – by End-user
10.1 Pharmaceutical and Biopharmaceutical Companies
10.1.1 Overview
10.1.2 Pharmaceutical and Biopharmaceutical Companies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Diagnostic and Research Laboratories
10.2.1 Overview
10.2.2 Diagnostic and Research Laboratories: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Academic Institutes
10.3.1 Overview
10.3.2 Academic Institutes: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Other End Users
10.4.1 Overview
10.4.2 Other End Users: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11. Genotyping Market – Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Genotyping Market Overview
11.2.2 North America: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.2.2.1 North America: Genotyping Market – Revenue and Forecast Analysis – by Product Type
11.2.2.2 North America: Genotyping Market – Revenue and Forecast Analysis – by Technology
11.2.2.3 North America: Genotyping Market – Revenue and Forecast Analysis – by Application
11.2.2.4 North America: Genotyping Market – Revenue and Forecast Analysis – by End-user
11.2.3 North America: Genotyping Market – Revenue and Forecast Analysis – by Country
11.2.3.1 United States: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.1.1 United States: Genotyping Market Breakdown, by Product Type
11.2.3.1.2 United States: Genotyping Market Breakdown, by Technology
11.2.3.1.3 United States: Genotyping Market Breakdown, by Application
11.2.3.1.4 United States: Genotyping Market Breakdown, by End-user
11.2.3.2 Canada: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.2.1 Canada: Genotyping Market Breakdown, by Product Type
11.2.3.2.2 Canada: Genotyping Market Breakdown, by Technology
11.2.3.2.3 Canada: Genotyping Market Breakdown, by Application
11.2.3.2.4 Canada: Genotyping Market Breakdown, by End-user
11.2.3.3 Mexico: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.3.1 Mexico: Genotyping Market Breakdown, by Product Type
11.2.3.3.2 Mexico: Genotyping Market Breakdown, by Technology
11.2.3.3.3 Mexico: Genotyping Market Breakdown, by Application
11.2.3.3.4 Mexico: Genotyping Market Breakdown, by End-user
11.3 Europe
11.3.1 Europe Genotyping Market Overview
11.3.2 Europe: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.3.2.1 Europe: Genotyping Market – Revenue and Forecast Analysis – by Product Type
11.3.2.2 Europe: Genotyping Market – Revenue and Forecast Analysis – by Technology
11.3.2.3 Europe: Genotyping Market – Revenue and Forecast Analysis – by Application
11.3.2.4 Europe: Genotyping Market – Revenue and Forecast Analysis – by End-user
11.3.3 Europe: Genotyping Market – Revenue and Forecast Analysis – by Country
11.3.3.1 United Kingdom: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.1.1 United Kingdom: Genotyping Market Breakdown, by Product Type
11.3.3.1.2 United Kingdom: Genotyping Market Breakdown, by Technology
11.3.3.1.3 United Kingdom: Genotyping Market Breakdown, by Application
11.3.3.1.4 United Kingdom: Genotyping Market Breakdown, by End-user
11.3.3.2 Germany: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.2.1 Germany: Genotyping Market Breakdown, by Product Type
11.3.3.2.2 Germany: Genotyping Market Breakdown, by Technology
11.3.3.2.3 Germany: Genotyping Market Breakdown, by Application
11.3.3.2.4 Germany: Genotyping Market Breakdown, by End-user
11.3.3.3 France: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.3.1 France: Genotyping Market Breakdown, by Product Type
11.3.3.3.2 France: Genotyping Market Breakdown, by Technology
11.3.3.3.3 France: Genotyping Market Breakdown, by Application
11.3.3.3.4 France: Genotyping Market Breakdown, by End-user
11.3.3.4 Spain: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.4.1 Spain: Genotyping Market Breakdown, by Product Type
11.3.3.4.2 Spain: Genotyping Market Breakdown, by Technology
11.3.3.4.3 Spain: Genotyping Market Breakdown, by Application
11.3.3.4.4 Spain: Genotyping Market Breakdown, by End-user
11.3.3.5 Italy: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.5.1 Italy: Genotyping Market Breakdown, by Product Type
11.3.3.5.2 Italy: Genotyping Market Breakdown, by Technology
11.3.3.5.3 Italy: Genotyping Market Breakdown, by Application
11.3.3.5.4 Italy: Genotyping Market Breakdown, by End-user
11.3.3.6 Rest of Europe: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.6.1 Rest of Europe: Genotyping Market Breakdown, by Product Type
11.3.3.6.2 Rest of Europe: Genotyping Market Breakdown, by Technology
11.3.3.6.3 Rest of Europe: Genotyping Market Breakdown, by Application
11.3.3.6.4 Rest of Europe: Genotyping Market Breakdown, by End-user
11.4 Asia Pacific
11.4.1 Asia Pacific Genotyping Market Overview
11.4.2 Asia Pacific: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.4.2.1 Asia Pacific: Genotyping Market – Revenue and Forecast Analysis – by Product Type
11.4.2.2 Asia Pacific: Genotyping Market – Revenue and Forecast Analysis – by Technology
11.4.2.3 Asia Pacific: Genotyping Market – Revenue and Forecast Analysis – by Application
11.4.2.4 Asia Pacific: Genotyping Market – Revenue and Forecast Analysis – by End-user
11.4.3 Asia Pacific: Genotyping Market – Revenue and Forecast Analysis – by Country
11.4.3.1 China: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.1.1 China: Genotyping Market Breakdown, by Product Type
11.4.3.1.2 China: Genotyping Market Breakdown, by Technology
11.4.3.1.3 China: Genotyping Market Breakdown, by Application
11.4.3.1.4 China: Genotyping Market Breakdown, by End-user
11.4.3.2 Japan: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.2.1 Japan: Genotyping Market Breakdown, by Product Type
11.4.3.2.2 Japan: Genotyping Market Breakdown, by Technology
11.4.3.2.3 Japan: Genotyping Market Breakdown, by Application
11.4.3.2.4 Japan: Genotyping Market Breakdown, by End-user
11.4.3.3 India: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.3.1 India: Genotyping Market Breakdown, by Product Type
11.4.3.3.2 India: Genotyping Market Breakdown, by Technology
11.4.3.3.3 India: Genotyping Market Breakdown, by Application
11.4.3.3.4 India: Genotyping Market Breakdown, by End-user
11.4.3.4 Australia: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.4.1 Australia: Genotyping Market Breakdown, by Product Type
11.4.3.4.2 Australia: Genotyping Market Breakdown, by Technology
11.4.3.4.3 Australia: Genotyping Market Breakdown, by Application
11.4.3.4.4 Australia: Genotyping Market Breakdown, by End-user
11.4.3.5 South Korea: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.5.1 South Korea: Genotyping Market Breakdown, by Product Type
11.4.3.5.2 South Korea: Genotyping Market Breakdown, by Technology
11.4.3.5.3 South Korea: Genotyping Market Breakdown, by Application
11.4.3.5.4 South Korea: Genotyping Market Breakdown, by End-user
11.4.3.6 Rest of APAC: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.6.1 Rest of APAC: Genotyping Market Breakdown, by Product Type
11.4.3.6.2 Rest of APAC: Genotyping Market Breakdown, by Technology
11.4.3.6.3 Rest of APAC: Genotyping Market Breakdown, by Application
11.4.3.6.4 Rest of APAC: Genotyping Market Breakdown, by End-user
11.5 Middle East and Africa
11.5.1 Middle East and Africa Genotyping Market Overview
11.5.2 Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.5.2.1 Middle East and Africa: Genotyping Market – Revenue and Forecast Analysis – by Product Type
11.5.2.2 Middle East and Africa: Genotyping Market – Revenue and Forecast Analysis – by Technology
11.5.2.3 Middle East and Africa: Genotyping Market – Revenue and Forecast Analysis – by Application
11.5.2.4 Middle East and Africa: Genotyping Market – Revenue and Forecast Analysis – by End-user
11.5.3 Middle East and Africa: Genotyping Market – Revenue and Forecast Analysis – by Country
11.5.3.1 Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3.1.1 Saudi Arabia: Genotyping Market Breakdown, by Product Type
11.5.3.1.2 Saudi Arabia: Genotyping Market Breakdown, by Technology
11.5.3.1.3 Saudi Arabia: Genotyping Market Breakdown, by Application
11.5.3.1.4 Saudi Arabia: Genotyping Market Breakdown, by End-user
11.5.3.2 South Africa: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3.2.1 South Africa: Genotyping Market Breakdown, by Product Type
11.5.3.2.2 South Africa: Genotyping Market Breakdown, by Technology
11.5.3.2.3 South Africa: Genotyping Market Breakdown, by Application
11.5.3.2.4 South Africa: Genotyping Market Breakdown, by End-user
11.5.3.3 United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3.3.1 United Arab Emirates: Genotyping Market Breakdown, by Product Type
11.5.3.3.2 United Arab Emirates: Genotyping Market Breakdown, by Technology
11.5.3.3.3 United Arab Emirates: Genotyping Market Breakdown, by Application
11.5.3.3.4 United Arab Emirates: Genotyping Market Breakdown, by End-user
11.5.3.4 Rest of Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3.4.1 Rest of Middle East and Africa: Genotyping Market Breakdown, by Product Type
11.5.3.4.2 Rest of Middle East and Africa: Genotyping Market Breakdown, by Technology
11.5.3.4.3 Rest of Middle East and Africa: Genotyping Market Breakdown, by Application
11.5.3.4.4 Rest of Middle East and Africa: Genotyping Market Breakdown, by End-user
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Genotyping Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 QIAGEN NV
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Merck KGaA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 EUROFINS GENOMICS
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Thermo Fisher Scientific Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioTek Instruments, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 XCELRIS GENOMICS
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 TRIMGEN CORPORATION
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Illumina Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Danaher Corp
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Bio-Rad Laboratories Inc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 GE HealthCare Technologies Inc
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Standard BioTools Inc
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Laboratory Corp of America Holdings
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Beckman Coulter Inc
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 BGI
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 Takara Bio Inc
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 DiaSorin SpA
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Genotyping Market Segmentation
Table 2. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 3. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 4. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 5. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by End-user
Table 6. North America: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 7. North America: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 8. North America: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 9. North America: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 10. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 11. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 12. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 13. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 14. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 15. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 16. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 17. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 18. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 19. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 20. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 21. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 22. Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 23. Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 24. Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 25. Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 26. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 27. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 28. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 29. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 30. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 31. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 32. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 33. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 34. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 35. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 36. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 37. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 38. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 39. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 40. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 41. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 42. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 43. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 44. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 45. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 46. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 47. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 48. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 49. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 50. Asia Pacific: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 51. Asia Pacific: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 52. Asia Pacific: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 53. Asia Pacific: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 54. China: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 55. China: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 56. China: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 57. China: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 58. Japan: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 59. Japan: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 60. Japan: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 61. Japan: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 62. India: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 63. India: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 64. India: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 65. India: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 66. Australia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 67. Australia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 68. Australia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 69. Australia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 70. South Korea: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 71. South Korea: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 72. South Korea: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 73. South Korea: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 74. Rest of APAC: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 75. Rest of APAC: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 76. Rest of APAC: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 77. Rest of APAC: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 78. Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 79. Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 80. Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 81. Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 82. Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 83. Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 84. Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 85. Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 86. South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 87. South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 88. South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 89. South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 90. United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 91. United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 92. United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 93. United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 94. Rest of Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 95. Rest of Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 96. Rest of Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 97. Rest of Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 98. Recent Organic Growth Strategies in Genotyping Market
Table 99. Recent Inorganic Growth Strategies in the Genotyping Market
Table 100. Glossary of Terms, Genotyping Market

LIST OF FIGURES

Figure 1. Genotyping Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Genotyping Market Revenue (US$ Million), 2021–2031
Figure 5. Genotyping Market Share (%) – by Product Type (2023 and 2031)
Figure 6. Instruments: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Reagents and Kits: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioinformatics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Genotyping Services: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Genotyping Market Share (%) – by Technology (2023 and 2031)
Figure 11. Microarray: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Capillary Electrophoresis: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Sequencing: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Polymerase Chain Reaction (PCR): Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Other Technologies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Genotyping Market Share (%) – by Application (2023 and 2031)
Figure 18. Pharmacogenomics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Diagnostics and Personalized Medicine: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Animal Genetics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Agricultural Biotechnology: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Other Applications: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Genotyping Market Share (%) – by End-user (2023 and 2031)
Figure 24. Pharmaceutical and Biopharmaceutical Companies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 25. Diagnostic and Research Laboratories: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 26. Academic Institutes: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Other End Users: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. Genotyping Market Breakdown by Region, 2023 and 2031 (%)
Figure 29. North America: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 30. North America: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 31. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. Europe: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 36. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 39. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. Asia Pacific: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Asia Pacific: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 44. China: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Japan: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. India: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. Australia: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 48. South Korea: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 49. Rest of APAC: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 50. Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 51. Middle East and Africa: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 52. Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. Rest of Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. Growth Strategies in Genotyping Market